Kinetics of the Thermal Transition of Carbamazepine Polymorphic Forms in the Solid State

Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives

“…The diffraction patterns of all the CBZ samples shown in Fig. 2 agreed with that of form III, given in the previous reports [3,21,22]. It can be concluded that recrystallization of CBZ from alcoholic solutions in the presence of additives did not cause any polymorphic changes and only crystal habit modification was observed.…”

A Novel Method for Estimation of Transition Temperature for Polymorphic Pairs in Pharmaceuticals Using Heat of Solution and Solubility Data.

“…2) were identical to those reported previously. 9,10,16,17) The results of TG and HPLC suggested that each of the polymorphs was not solvated and did not decompose.…”

An Accurate Quantitative Analysis of Polymorphic Content by Chemometric X-ray Powder Diffraction

“…[13][14][15][16][17][18][19][20] The three principal polymorphs (e.g. the primitive monoclinic polymorph (form I), trigonal polymorph (form II) and triclinic polymorph (form III)) and dihydrate (form IV) have been well characterized by XRD, DSC, 13 C-NMR, FT-IR, and Raman spectroscopy.…”

“…[13][14][15][16][17][18][19][20] The three principal polymorphs (e.g. the primitive monoclinic polymorph (form I), trigonal polymorph (form II) and triclinic polymorph (form III)) and dihydrate (form IV) have been well characterized by XRD, DSC, 13 C-NMR, FT-IR, and Raman spectroscopy. [21][22][23][24][25] The polymorphic content of pharmaceuticals is determined and predicted by the XRD method, but this method has relatively large errors, of around ±5%, due to the crystal orientation when the sample powder is loaded on the glass plate.…”